Incannex Healthcare Limited (IXHL)
Last updated: 2026-10-24 14:18:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Incannex Healthcare Limited (IXHL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.66, with a market capitalization of $32.62M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.49 to $14.91. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$32.62M | |
$2.65 | |
$2,700.00 | |
$2.40 | |
$2.60 | |
307.00 | |
84.41K | |
-- | |
$14.91 | |
$2.49 | |
-- | |
-- |
Incannex Healthcare Limited (IXHL) Latest Closing Stock Price
Incannex Healthcare Limited (IXHL) last closed at $2.60 as of 2026-10-23 23:51:00, unchanged from the previous close of $2.60.
During the latest regular trading session, IXHL traded between $2.40 and $2,700.00, with a volume of 307.00 shares. The closing price was near the lower end and near the lower end of its 52-week range.
Incannex Healthcare Limited (IXHL) 7-Day Stock Price Change
Over the past seven days, Incannex Healthcare Limited (IXHL) moved from $2.88 to $2.66, representing a decline of 7.50% ($0.22).
The stock traded between $2.55 and $2.94 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 63.82 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
IXHL 52-Week Price Position
Position in Range: 1.4%
IXHL is currently trading at $2.66, placing it 1.4% of the way from its 52-week low of $2.49 to its 52-week high of $14.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Incannex Healthcare Limited (IXHL)?
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
Incannex Healthcare Limited Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 12 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Incannex Healthcare Limited (IXHL) Stock on MEXC
Eligible investors can buy real shares of Incannex Healthcare Limited (IXHL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Incannex Healthcare Limited (IXHL) stock price today?
2.Is IXHL stock going up or down today?
3.What is IXHL pre-market price?
4.What is IXHL after-hours price?
5.Is IXHL stock trading now?
6.Where does IXHL sit relative to its 52-week high and low?
7.What sector is Incannex Healthcare Limited in?
8.What is Incannex Healthcare Limited's market capitalization and where is it listed?
9.How is IXHL valued in terms of P/E ratio and EPS?
10.Does Incannex Healthcare Limited pay a dividend?
Explore More US Stocks
Search Stocks
IXHL Stock Calculator
Estimate the value between IXHL shares and USD.
IXHL Shares to USD
1.00 IXHL shares = 2.664 USD
Calculations are estimates based on the latest available price and are for reference only.


